Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence

Glaucoma, the leading cause of irreversible blindness, affects >70 million people worldwide. Lowering intraocular pressure via topical administration of eye drops is the most common first-line therapy for glaucoma. This treatment paradigm has notoriously high non-adherence rates: ranging from 30%...

Full description

Bibliographic Details
Main Authors: Marcelo Aguilar-Rivera, Dieanira T. Erudaitius, Vincent M. Wu, Justin C. Tantiongloc, Dae Y. Kang, Todd P. Coleman, Sally L. Baxter, Robert N. Weinreb
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Sensors
Subjects:
Online Access:https://www.mdpi.com/1424-8220/20/9/2570
id doaj-51738388dfed40099c8923207ed8ec0c
record_format Article
spelling doaj-51738388dfed40099c8923207ed8ec0c2020-11-25T02:39:03ZengMDPI AGSensors1424-82202020-04-01202570257010.3390/s20092570Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication AdherenceMarcelo Aguilar-Rivera0Dieanira T. Erudaitius1Vincent M. Wu2Justin C. Tantiongloc3Dae Y. Kang4Todd P. Coleman5Sally L. Baxter6Robert N. Weinreb7Department of Bioengineering, University of California San Diego, La Jolla, San Diego, CA 92093, USADepartment of Bioengineering, University of California San Diego, La Jolla, San Diego, CA 92093, USADepartment of Bioengineering, University of California San Diego, La Jolla, San Diego, CA 92093, USADepartment of Computer Science and Engineering, University of California San Diego, La Jolla, San Diego, CA 92093, USADepartment of Bioengineering, University of California San Diego, La Jolla, San Diego, CA 92093, USADepartment of Bioengineering, University of California San Diego, La Jolla, San Diego, CA 92093, USAHamilton Glaucoma Center, Viterbi Family Department of Ophthalmology and Shiley Eye Institute, University of California San Diego, La Jolla, San Diego, CA 92093, USADepartment of Bioengineering, University of California San Diego, La Jolla, San Diego, CA 92093, USAGlaucoma, the leading cause of irreversible blindness, affects >70 million people worldwide. Lowering intraocular pressure via topical administration of eye drops is the most common first-line therapy for glaucoma. This treatment paradigm has notoriously high non-adherence rates: ranging from 30% to 80%. The advent of smart phone enabled technologies creates promise for improving eyedrop adherence. However, previous eyedrop electronic monitoring solutions had awkward medication bottle adjuncts and crude software for monitoring the administration of a drop that adversely affected their ability to foster sustainable improvements in adherence. The current work begins to address this unmet need for wireless technology by creating a “smart drop” bottle. This medication bottle is instrumented with sensing electronics that enable detection of each eyedrop administered while maintaining the shape and size of the bottle. This is achieved by a thin electronic force sensor wrapped around the bottle and underneath the label, interfaced with a thin electronic circuit underneath the bottle that allows for detection and wireless transmission to a smart-phone application. We demonstrate 100% success rate of wireless communication over 75 feet with <1% false positive and false negative rates of single drop deliveries, thus providing a viable solution for eyedrop monitoring for glaucoma patients.https://www.mdpi.com/1424-8220/20/9/2570Glaucomaadherencemonitoringsensorsalertsclinical decision support
collection DOAJ
language English
format Article
sources DOAJ
author Marcelo Aguilar-Rivera
Dieanira T. Erudaitius
Vincent M. Wu
Justin C. Tantiongloc
Dae Y. Kang
Todd P. Coleman
Sally L. Baxter
Robert N. Weinreb
spellingShingle Marcelo Aguilar-Rivera
Dieanira T. Erudaitius
Vincent M. Wu
Justin C. Tantiongloc
Dae Y. Kang
Todd P. Coleman
Sally L. Baxter
Robert N. Weinreb
Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence
Sensors
Glaucoma
adherence
monitoring
sensors
alerts
clinical decision support
author_facet Marcelo Aguilar-Rivera
Dieanira T. Erudaitius
Vincent M. Wu
Justin C. Tantiongloc
Dae Y. Kang
Todd P. Coleman
Sally L. Baxter
Robert N. Weinreb
author_sort Marcelo Aguilar-Rivera
title Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence
title_short Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence
title_full Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence
title_fullStr Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence
title_full_unstemmed Smart Electronic Eyedrop Bottle for Unobtrusive Monitoring of Glaucoma Medication Adherence
title_sort smart electronic eyedrop bottle for unobtrusive monitoring of glaucoma medication adherence
publisher MDPI AG
series Sensors
issn 1424-8220
publishDate 2020-04-01
description Glaucoma, the leading cause of irreversible blindness, affects >70 million people worldwide. Lowering intraocular pressure via topical administration of eye drops is the most common first-line therapy for glaucoma. This treatment paradigm has notoriously high non-adherence rates: ranging from 30% to 80%. The advent of smart phone enabled technologies creates promise for improving eyedrop adherence. However, previous eyedrop electronic monitoring solutions had awkward medication bottle adjuncts and crude software for monitoring the administration of a drop that adversely affected their ability to foster sustainable improvements in adherence. The current work begins to address this unmet need for wireless technology by creating a “smart drop” bottle. This medication bottle is instrumented with sensing electronics that enable detection of each eyedrop administered while maintaining the shape and size of the bottle. This is achieved by a thin electronic force sensor wrapped around the bottle and underneath the label, interfaced with a thin electronic circuit underneath the bottle that allows for detection and wireless transmission to a smart-phone application. We demonstrate 100% success rate of wireless communication over 75 feet with <1% false positive and false negative rates of single drop deliveries, thus providing a viable solution for eyedrop monitoring for glaucoma patients.
topic Glaucoma
adherence
monitoring
sensors
alerts
clinical decision support
url https://www.mdpi.com/1424-8220/20/9/2570
work_keys_str_mv AT marceloaguilarrivera smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
AT dieaniraterudaitius smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
AT vincentmwu smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
AT justinctantiongloc smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
AT daeykang smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
AT toddpcoleman smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
AT sallylbaxter smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
AT robertnweinreb smartelectroniceyedropbottleforunobtrusivemonitoringofglaucomamedicationadherence
_version_ 1724787988607533056